Relation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsia

Ginekologia Polska
|June 30, 2015
PubMed

Insights

Platelet crit (PCT) and platelet distribution width (PDW) levels are linked to preeclampsia and its severity. Lower PCT and higher PDW were observed in preeclamptic women, with increased PDW in severe cases.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Cardiovascular Research

Background:

  • Preeclampsia is a serious pregnancy complication.
  • The association between platelet parameters like platelet crit (PCT) and platelet distribution width (PDW) and preeclampsia requires further investigation.

Purpose of the Study:

  • To explore the correlation between PCT and PDW with the presence and severity of preeclampsia.

Main Methods:

  • A case-control study involving 110 preeclamptic and 100 healthy pregnant women.
  • Platelet crit (PCT) and platelet distribution width (PDW) were measured using an automatic blood counter.

Main Results:

  • Preeclamptic women showed significantly higher PDW, mean platelet volume (MPV), blood pressure, and inflammatory markers compared to controls.
  • Platelet crit (PCT) levels were significantly lower in the preeclampsia group.
  • PDW and MPV levels were elevated in severe preeclampsia compared to mild cases.

Conclusions:

  • PCT and PDW levels are associated with both the occurrence and severity of preeclampsia.
  • These platelet indices may serve as potential biomarkers for preeclampsia.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
683
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
638
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K